Christian Angermayer

In 2000, Angermayer co-founded the biotechnology company Ribopharma AG; in 2003 it merged with its US peer Alnylam Pharmaceuticals, and the combined company subsequently went public and became the first commercial RNA interference (RNAi) technology company.⁠[1][2]

In 2012, he founded Apeiron Investment Group, his family office and merchant banking business, which invests across life sciences, fintech, deep technology and hospitality and is owned and controlled by him.⁠[3][4][4]

Since Ribopharma, he has created, co-founded or invested in numerous companies; he says he has raised about US$2 billion for his portfolio companies and has been involved in more than 40 IPO and M&A transactions as an entrepreneur, investor or adviser.⁠[1][1]

In 2018, he founded atai Life Sciences together with Florian Brand, Srinivas Rao and Lars Christian Wilde; the biotechnology company develops treatments for mental health disorders through approaches that include psychedelic compounds. atai also made a strategic investment in COMPASS Pathways.⁠[4][2][4]

Since 2019, he has served as general partner of Presight Capital, a venture capital fund he founded, and as a director of the longevity-focused biotechnology companies Cambrian Biopharma and Rejuveron Life Sciences (later renamed Centenara Labs).⁠[3][3]

In January 2021, atai entered into a consulting agreement with him under which he would advise the company on business and financing strategy and receive compensation tied to performance targets. As of May 31, 2021, Apeiron held a 21.1% interest in atai.⁠[4][4][4]

In March 2021, Frontier Acquisition Corp., a special purpose acquisition company of which he was chief executive officer, offered 20 million units at US$10 each in its initial public offering. On March 8, 2023, the company announced that it would redeem all of its Class A shares because it would not complete a business combination within the required period.⁠[1][1][5][5]

On May 11, 2021, Block.one announced the launch of the digital asset platform Bullish GlobalBullishBullish (NYSE: BLSH) is an institutionally focused global digital asset platform whose formation was announced by Block.one on May 11, 2021; its main businesses are Bullish Exchange (a digital asset spot and derivatives exchange) and CoinDesk’s indices, data, media and events businesses. It listed on the NYSE in August 2025 and obtained a New York State Department of Financial Services BitLicense in September; in May 2026 it announced a $4.2 billion acquisition of Equiniti (pending completion), and in August it launched trading of tokenized BLSH shares on its exchange regulated by the Gibraltar Financial Services Commission. The company is a foreign private issuer with its principal executive offices in Grand Cayman, Cayman Islands.Open the full entry, whose initial capital included US$100 million in cash, 164,000 bitcoin and 20 million EOS injected by Block.one, plus a separately completed US$300 million strategic investment round. Angermayer was among the investors leading that round and, together with Peter ThielPeter ThielPeter Thiel is an American entrepreneur and investor, a co-founder of PayPal and Palantir Technologies, and the first outside investor in Facebook. He is a partner at the venture capital firm Founders Fund and founded the Thiel Fellowship, which funds young people to leave college and build new things; his public skepticism of higher education, his support for Trump in 2016, and his funding of litigation against Gawker Media have drawn controversy.Open the full entry, Alan HowardAlan HowardAlan Howard is a British macro hedge fund manager who in 2002 co-founded Brevan Howard with fellow traders from Credit Suisse First Boston and built it into one of Europe’s largest hedge fund managers. After stepping down as chief executive in 2019, he focused on his own trading, and in 2021 he took part in Bullish’s strategic funding round and became a senior advisor to the company.Open the full entry and Richard LiRichard LiRichard Li (Li Tzar Kai) is a Hong Kong entrepreneur and investor. He founded the pan-Asian satellite television network Star TV in the early 1990s and, after selling a controlling stake to News Corporation in 1993, founded the private investment group Pacific Century Group (PCG). He has been chairman of PCCW since 1999 and is executive chairman of HKT; the insurer FWD, which he founded in 2013, listed on the Hong Kong Stock Exchange in 2025.Open the full entry, became a senior adviser to Bullish.⁠[6][6][6][7]

In June 2021, atai offered 15 million common shares at US$15 each in its initial public offering on the Nasdaq Global Market under the symbol “ATAI,” for gross proceeds of US$225 million. At the listing he became chairman of the company’s supervisory board.⁠[4][4][4][4]

On November 5, 2025, atai completed its acquisition of Beckley Psytech Limited and changed its name to Atai Beckley N.V.; on December 30 that year, the company moved its domicile from the Netherlands to the United States, becoming AtaiBeckley Inc., with its stock continuing to trade on Nasdaq as “ATAI.” He remains chairman of the board; because of his relationship with Apeiron, a principal stockholder, and his consultancy agreement with the company, he is not considered an independent director.⁠[8][8][8][3][3]

He is co-founder and non-employee executive chairman of Enhanced, whose core business is the Enhanced Games, a multisport event at which athletes may take substances on the World Anti-Doping Agency’s prohibited list. On May 7, 2026, Enhanced completed its combination with the special purpose acquisition company A Paradise Acquisition Corp., and on May 8 it began trading on the New York Stock Exchange as Enhanced Group Inc. under the symbol “ENHA.” The first Enhanced Games were held on May 24, 2026, at a purpose-built complex at Resorts World Las Vegas.⁠[2][2][2][2]

As of August 19, 2026, through Enhanced Holdings LP, which is controlled by Apeiron, he held about 29.8% of Enhanced Group’s Class A shares and all of its Class B shares, together about 96.5% of the voting power. In June 2026, Apeiron took part in a private placement of about US$50 million by the company, agreeing to buy about US$20 million.⁠[2][2][2][2][2]

As of October 2026, Apeiron says it manages about US$7 billion of internal and external capital, with teams in New York, London, Berlin, Abu Dhabi and Malta and a primary focus on the United States; its investments include direct stakes in private and listed companies as well as anchor LP investments combined with GP stakes in emerging asset managers, with a focus on biotech, fintech and crypto, deep tech, experiences, hospitality and sports, real estate, and natural resources.⁠[9][9][9][9]

Apeiron regards spearheading the renaissance of psychedelics as treatments for mental health as its most defiant achievement; he personally collects ancient art centered on the history of psychedelics.⁠[9][9]

He is a Young Global Leader of the World Economic Forum, a partner of the Munich Security Conference, a member of the Milken Institute Young Leaders Circle, a member of the Court of the London School of Hygiene and Tropical Medicine, and a member of the Global Advisory Council of the Wilson Center.⁠[1][1]

Apeiron Investment Group: Official website: https://apeiron-investments.com/ (opens in a new window).⁠[9]

AtaiBeckley: Official website: https://www.ataibeckley.com/ (opens in a new window).⁠[3]

X: Public account: https://x.com/C_Angermayer (opens in a new window)⁠[9]

LinkedInLinkedInLinkedIn is a social networking platform for professionals. It was founded in 2002 by Reid Hoffman and others, launched in 2003, and listed on the New York Stock Exchange in 2011; after Microsoft acquired it for approximately $26.2 billion in 2016, it became a wholly owned Microsoft subsidiary. Its revenue comes from membership subscriptions, advertising, and recruitment solutions.Open the full entry: Public profile: https://www.linkedin.com/in/christian-angermayer/ (opens in a new window)⁠[9]

Substack: Public account: https://christianangermayer.substack.com/ (opens in a new window)⁠[9]